Approximately Half News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Approximately Half. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Approximately Half Today - Breaking & Trending Today

Mineralys Therapeutics Announces Positive Topline Phase 2 Data for MLS-101 in the Target-HTN Trial Evaluating the Treatment of Uncontrolled and Resistant Hypertension

Published: November 16, 2022

Successfully Met Primary and Secondary Endpoints, with Mean Placebo-Adjusted Reduction in Systolic Blood Pressure of 9.7 mmHg in Uncontrolled and Resistant...

Source: prnewswire.com

Related Topics:

United StatesDavid RodmanJon CongletonCatalys PacificMelyssa WeiblePrnewswire Mineralys Therapeutics IncUniversity Of Maryland School MedicineMitsubishi Tanabe Pharma CorporationElixir Health Public RelationsUniversity Of Maryland Medical CenterDivision Of NephrologyMineralys Therapeutics IncSuccessfully Met PrimarySecondary EndpointsMean Placebo Adjusted ReductionSystolic Blood PressureResistant Hypertensive SubjectsOnce DailyThiazide DiureticApproximately HalfStudy PopulationSerum CortisolModest IncreaseRapid ReversibilityChief Executive Officer

LANNETT PROVIDES UPDATE ON PIVOTAL CLINICAL TRIAL FOR BIOSIMILAR INSULIN GLARGINE

Published: June 1, 2022

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today provided an update on its ongoing pivotal clinical trial of biosimilar insulin glargine, a product the...

Source: prnewswire.com

Related Topics:

Sanofi LantusRobert JaffeCompany FormLannett CompanyPrnewswire Lannett Company IncLannett Company IncRobert Jaffe CoApproximately HalfPlanned NumberSubjects Have ReceivedFirst DoseWith No Reported Serious AdverseTim CrewBiologics License ApplicationMedical Pharmaceuticals Health Care Amp Hospitals Clinical Trials Amp Medical Discoveries